Lung cancer resistance: the key is glucose

(Ecole Polytechnique Fédérale de Lausanne) Lung tumors are home to immune cells that affect their growth and resistance to treatment. Looking at neutrophils, scientists led by EPFL have discovered that the key might lie in the cells' ability to metabolize glucose, opening an entirely new target for improving radiotherapy.